[Correspondence] Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma

We read with interest the study by David Cunningham and colleagues1 on peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma.

http://ift.tt/2oVpML6